Treatment of 5q-syndrome with lenalidomide in an HIV-positive patient under cART.
Blum
Sabine
S
Cavassini
Matthias
M
Lambert
Jean-François
JF
Fayet
Aurélie
A
Schapira
Marc
M
Jotterand
Martine
M
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D000077269:Lenalidomide; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D013792:Thalidomide; D000077269:Lenalidomide